Active bilingualism delays the onset of mild cognitive impairment


Por: Calabria, M, Hernandez, M, Cattaneo, G, Suades, A, Serra, M, Juncadella, M, Rene, R, Sala, I, Lleo, A, Ortiz-Gil, J, Ugas, L, Avila, A, Ruiz, IG, Avila, C, Costa, A

Publicada: 1 sep 2020 Ahead of Print: 12 jun 2020
Resumen:
Lifelong bilingualism may contribute to cognitive reserve (CR) in neurodegenerative diseases as shown by a delay of the age at symptom onset in bilinguals with Alzheimer's disease (AD) and Mild Cognitive Impairment (MCI). However, some studies have failed to show this bilingual advantage, suggesting that it might depend on the type and degree of bilingualism. In the present study, we tested the hypothesis that active bilingualism, defined as the continuous use of the two languages as opposed to second language exposition only, may protect against cognitive decline. Moreover, we investigated whether bilingualism as a CR factor may be explained by an advantage within the executive control (EC) system. To do so, we collected clinical measures (age at onset of cognitive symptoms, age at the first medical visit for cognitive impairments, and age at diagnosis) in patients with MCI and patients with AD with different degrees of language experience and usage of Catalan and Spanish. Additionally, all participants were tested on four EC tasks and one long-term memory recognition task. First, results from multiple regression analyses showed that active bilingualism was a significant predictor of delay in the age at onset for all the clinical measures in MCI, but not AD patients. Second, the effect of active bilingualism was independent of occupation, educational level and job attainment across the individuals' lifespan. Finally, although we did not find an effect of active bilingualism across all EC tasks, we did find an effect for conflict resolution. These results are discussed in the context of CR hypotheses, suggesting that compensatory mechanisms may play a role in protecting against cognitive decline.

Filiaciones:
Calabria, M:
 Pompeu Fabra Univ, Ctr Brain & Cognit, Barcelona, Spain

 Univ Oberta Catalunya, Fac Hlth Sci, Rambla del Poblenou 156, Barcelona 08018, Spain

Hernandez, M:
 Univ Barcelona, Inst Neurociencies, Dept Cognit Dev & Educ Psychol, Cognit & Brain Plast Grp, Barcelona, Spain

Cattaneo, G:
 Inst Univ Neurorehabil Adscrit UAB, Inst Guttmann, Badalona, Spain

 Inst Invest Biomed August Pi & Sunyer IDIBAP, Barcelona, Spain

Suades, A:
 Fundacio Neurorehabil & Recerca Cognit, ENTIA, Barcelona, Spain

 Bellvitge Univ Hosp, Funct Dementia Unit, Lhospitalet De Llobregat, Spain

Serra, M:
 Pompeu Fabra Univ, Ctr Brain & Cognit, Barcelona, Spain

Juncadella, M:
 Fundacio Neurorehabil & Recerca Cognit, ENTIA, Barcelona, Spain

 Bellvitge Univ Hosp, Funct Dementia Unit, Lhospitalet De Llobregat, Spain

Rene, R:
 Bellvitge Univ Hosp, Funct Dementia Unit, Lhospitalet De Llobregat, Spain

Sala, I:
 Hosp Santa Creu & Sant Pau, Memory Unit, Neurol Dept, Barcelona, Spain

Lleo, A:
 Hosp Santa Creu & Sant Pau, Memory Unit, Neurol Dept, Barcelona, Spain

Ortiz-Gil, J:
 Hosp Gen Granollers, Barcelona, Spain

 FIDMAG Sisters Hosp Res Fdn, Barcelona, Spain

Ugas, L:
 Hosp Gen Granollers, Barcelona, Spain

 Hosp Benito Menni, CASM, Barcelona, Spain

Avila, A:
 Hosp Moises Broggi, Neurol Dept, Consorci Sanitari Integral, Barcelona, Spain

Ruiz, IG:
 Hosp Moises Broggi, Neurol Dept, Consorci Sanitari Integral, Barcelona, Spain

Avila, C:
 Univ Jaume 1, Dept Basic Psychol Clin Psychol & Psychobiol, Neuropsychol & Funct Imaging Grp, Castellon de La Plana, Spain

Costa, A:
 Pompeu Fabra Univ, Ctr Brain & Cognit, Barcelona, Spain

 Inst Catalana Recerca & Estudis Avancats ICREA, Barcelona, Spain
ISSN: 00283932
Editorial
PERGAMON-ELSEVIER SCIENCE LTD, THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND, Reino Unido
Tipo de documento: Article
Volumen: 146 Número:
Páginas: 107528-107528
WOS Id: 000573020100011
ID de PubMed: 32540266
imagen Green Published

MÉTRICAS